Viasonix

Company Overview

Snapshot

Founded in December 2008, Viasonix operates with 1–10 employees. The company specializes in advanced vascular diagnostic and home care products, holding numerous regulatory clearances including FDA, CE, and Health Canada, which underscores its global market readiness.

Business overview

Viasonix is a medical device company that develops and produces vascular diagnostic systems, primarily utilizing Doppler and pneumatic technologies. Its product portfolio includes the Sonara and Sonara-Tek TCD systems, the Quantix/ND for noninvasive volume blood flow, the Quantix/OR for intra-operative blood flow, the Quantix/TE for trans-esophageal volume flow diagnosis, and the WalkCare and D-Flex devices for deep vein thrombosis prevention. The company serves the healthcare and life sciences sectors, targeting providers and patients globally with its B2B business model.

Company Intelligence Q&A

What is Viasonix's primary focus in the medical device market?

Viasonix primarily focuses on the development and production of advanced vascular diagnostic systems, utilizing Doppler and pneumatic technologies for various medical applications.

Which key products has Viasonix successfully commercialized?

Viasonix has commercialized products such as the Sonara and Sonara-Tek TCD systems, the Quantix/ND for noninvasive volume blood flow, the Quantix/OR for intra-operative blood flow, the Quantix/TE for trans-esophageal volume flow diagnosis, and the WalkCare and D-Flex devices for deep vein thrombosis prevention.

What regulatory clearances does Viasonix hold for its products?

Viasonix holds numerous regulatory clearances, including FDA, CE, Health Canada, TFDA, CFDA, KFDA, ANVISA, INVIMA, TGA, and AMAR, demonstrating its compliance with international medical device standards.

In which markets does Viasonix operate?

Viasonix operates in global markets, including the United States, Europe, Australia, Canada, Thailand, Hong Kong, and South America.

What is Viasonix's business model and target customer base?

Viasonix operates on a B2B business model, targeting healthcare providers and patients within the healthcare and life sciences sectors.